ALFUZOSIN HYDROCHLORIDE EXTENDED RELEASE

Generic: ALFUZOSIN HYDROCHLORIDE

Cipla USA Inc.Manufacturer
ORALRoute
ALFUZOSIN HYDROCHLORIDEActive Substance
2012-01-17Original Approval

ALFUZOSIN HYDROCHLORIDE EXTENDED RELEASE is FDA application ANDA090284, sponsored by INVAGEN PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2017-01-05
Alfuzosin Hydrochloride Extended-release Tablets, 10 mg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical

Presence of Foreign Substance: consumer complaint for foreign matter embedded in the tablet identifi

Top Reported Reactions

1
DRUG INEFFECTIVE
119 reports
2
OFF LABEL USE
104 reports
3
DRUG INTERACTION
102 reports
4
DYSPNOEA
94 reports
5
FATIGUE
94 reports
6
ACUTE KIDNEY INJURY
87 reports
7
DIZZINESS
77 reports
8
DIARRHOEA
76 reports
9
HYPOTENSION
74 reports
10
ASTHENIA
70 reports